Sensus Healthcare (SRTS) Stock Price

Sensus Healthcare Price

NASDAQ·CLOSED
2.91USD+0.02 (+0.69 %)
Market closed

Over the last 13 years Sensus Healthcare grew revenue by 11.1% annually, reaching 27.48 M USD. Earnings per share have grown at 17.7% per year over the last 3 years. For Sensus Healthcare, the net margin of -28.1% is down versus 15.2% a few years ago. The consensus 12-month price target for Sensus Healthcare is 6.12 USD, about 110.3% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 8% above its 52-week low.

Sensus Healthcare stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sensus Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sensus Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sensus Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sensus Healthcare Stock Price History
DateSensus Healthcare Price
7/31/20262.91 USD
7/30/20262.89 USD
7/29/20262.82 USD
7/27/20263.05 USD
7/23/20262.94 USD
7/22/20263.04 USD
7/21/20263.04 USD
7/20/20263.10 USD
7/17/20263.02 USD
7/16/20263.02 USD
7/15/20263.08 USD
7/14/20263.08 USD
7/13/20263.23 USD
7/10/20263.05 USD
7/9/20262.92 USD
7/8/20262.96 USD
7/7/20263.09 USD
7/6/20263.05 USD
7/2/20263.07 USD
7/1/20263.03 USD
6/30/20263.02 USD
6/29/20263.06 USD
6/26/20263.04 USD
6/25/20262.95 USD
6/24/20263.03 USD
6/23/20262.74 USD
6/22/20262.80 USD
6/18/20262.79 USD
6/17/20262.73 USD
6/16/20262.71 USD
6/15/20262.71 USD
6/12/20262.71 USD
6/11/20262.71 USD
6/10/20262.82 USD
6/9/20262.70 USD
6/8/20262.69 USD
6/5/20262.70 USD
6/4/20262.82 USD
6/3/20262.84 USD
6/2/20262.84 USD
6/1/20262.85 USD
5/29/20263.09 USD
5/28/20263.18 USD
5/27/20263.13 USD
5/26/20263.20 USD
5/22/20263.19 USD
5/21/20263.23 USD
5/20/20263.32 USD
5/19/20263.35 USD
5/18/20263.47 USD
5/15/20263.61 USD
5/14/20263.61 USD
5/13/20263.45 USD
5/12/20263.37 USD
5/11/20263.41 USD
5/8/20263.08 USD
5/7/20264.11 USD
5/6/20264.09 USD
5/5/20263.93 USD
5/4/20263.96 USD
4/22/20264.04 USD
4/21/20263.99 USD
4/20/20264.06 USD
4/17/20264.49 USD
4/16/20264.44 USD
4/15/20264.49 USD
4/14/20264.49 USD
4/13/20264.43 USD
4/10/20264.49 USD
4/9/20264.47 USD
4/8/20264.42 USD
4/7/20264.38 USD
4/6/20264.23 USD
4/2/20264.11 USD
4/1/20264.20 USD
3/31/20263.98 USD
3/30/20263.87 USD
3/27/20263.92 USD
3/26/20264.01 USD
3/25/20264.22 USD
3/24/20263.96 USD
3/23/20264.11 USD
3/20/20263.87 USD
3/19/20263.98 USD
3/18/20263.98 USD
3/17/20263.91 USD
3/16/20263.96 USD
3/13/20263.92 USD
3/12/20263.98 USD
3/11/20264.10 USD
3/10/20264.25 USD
3/9/20264.35 USD
3/6/20264.25 USD
3/5/20264.28 USD
3/4/20264.41 USD
3/3/20264.61 USD
3/2/20264.59 USD
2/27/20264.11 USD
2/26/20264.02 USD
2/25/20263.99 USD
2/24/20263.84 USD
2/23/20263.83 USD
2/20/20263.95 USD
2/19/20263.91 USD
2/18/20263.85 USD
2/17/20263.83 USD
2/13/20263.91 USD
2/12/20263.61 USD
2/11/20264.76 USD
2/10/20264.91 USD
2/9/20264.91 USD
2/6/20265.10 USD
2/5/20264.84 USD
2/4/20264.89 USD
2/3/20265.18 USD
2/2/20265.11 USD
1/30/20265.13 USD
1/29/20265.18 USD
1/28/20265.11 USD
1/27/20265.04 USD
1/26/20265.09 USD
1/23/20264.83 USD
1/22/20264.97 USD
1/21/20264.96 USD
1/20/20264.96 USD
1/16/20265.32 USD
1/15/20264.96 USD
1/14/20264.98 USD
1/13/20265.27 USD
1/12/20264.61 USD
1/9/20264.76 USD
1/8/20264.31 USD
1/7/20264.39 USD
1/6/20264.46 USD
1/5/20264.45 USD
1/2/20264.10 USD
12/31/20253.98 USD
12/30/20253.70 USD
12/29/20253.76 USD
12/26/20253.79 USD
12/24/20253.79 USD
12/23/20253.79 USD
12/22/20253.81 USD
12/19/20253.83 USD
12/18/20253.84 USD
12/17/20253.77 USD
12/16/20253.80 USD
12/15/20253.69 USD
12/12/20253.83 USD
12/11/20253.89 USD
12/10/20254.00 USD
12/9/20253.83 USD
12/8/20253.81 USD
12/5/20253.90 USD
12/4/20253.98 USD
12/3/20254.01 USD
12/2/20254.06 USD
12/1/20254.00 USD
11/28/20254.19 USD
11/26/20254.11 USD
11/25/20254.26 USD
11/24/20254.02 USD
11/21/20254.02 USD
11/20/20253.93 USD
11/19/20254.06 USD
11/18/20254.04 USD
11/17/20253.99 USD
11/14/20254.42 USD
11/13/20254.46 USD
11/12/20254.60 USD
11/11/20254.21 USD
11/10/20254.34 USD
11/7/20254.07 USD
11/6/20253.61 USD
11/5/20253.65 USD
11/4/20253.48 USD
11/3/20253.10 USD
10/31/20253.20 USD
10/30/20253.18 USD
10/29/20253.21 USD
10/28/20253.27 USD
10/27/20253.26 USD
10/24/20253.39 USD
10/23/20253.29 USD
10/22/20253.22 USD
10/21/20253.23 USD
10/20/20253.18 USD
10/17/20253.20 USD
10/16/20253.31 USD
10/15/20253.48 USD
10/14/20253.22 USD
10/13/20253.21 USD
10/10/20253.28 USD
10/9/20253.40 USD
10/8/20253.45 USD
10/7/20253.55 USD
10/6/20253.41 USD
10/3/20253.46 USD
10/2/20253.34 USD
10/1/20253.16 USD
9/30/20253.14 USD
9/29/20253.17 USD
9/28/20253.17 USD
9/25/20253.10 USD
9/24/20253.13 USD
9/23/20253.16 USD
9/22/20253.15 USD
9/19/20253.11 USD
9/18/20253.14 USD
9/17/20253.09 USD
9/16/20253.15 USD
9/15/20253.14 USD
9/12/20253.20 USD
9/11/20253.24 USD
9/10/20253.20 USD
9/9/20253.29 USD
9/8/20253.23 USD
9/5/20253.16 USD
9/4/20253.18 USD
9/3/20253.25 USD
9/2/20253.38 USD
8/29/20253.44 USD
8/28/20253.30 USD
8/27/20253.31 USD
8/26/20253.29 USD
8/25/20253.13 USD
8/22/20253.25 USD
8/21/20253.27 USD
8/20/20253.18 USD
8/19/20253.20 USD
8/18/20253.31 USD
8/15/20253.36 USD
8/14/20253.44 USD
8/13/20253.42 USD
8/12/20253.27 USD
8/11/20253.19 USD
8/8/20253.51 USD
8/7/20253.70 USD
8/6/20255.33 USD
8/5/20255.25 USD
8/4/20255.50 USD
Access this data via the Eulerpool API
Get Free API Key

Sensus Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
44.53 M USD
14.83 M USD
24.24 M USD
Jan 1, 2023
24.41 M USD
-382,000.00 USD
485,000.00 USD
Jan 1, 2024
41.81 M USD
8.09 M USD
6.65 M USD
Jan 1, 2025
27.48 M USD
-10.31 M USD
-7.72 M USD
Jan 1, 2026 (e)
21.99 M USD
2.96 M USD
-6.82 M USD
Jan 1, 2027 (e)
31.34 M USD
4.22 M USD
-1.88 M USD
Jan 1, 2028 (e)
36.60 M USD
4.93 M USD
897,979.50 USD
Jan 1, 2029 (e)
78.48 M USD
10.57 M USD
11.10 M USD

Sensus Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 3, 2026, 4:38 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
5.0010.0014.0020.0026.0027.009.0027.0044.0024.0041.0027.0021.0031.0036.0078.00
-50.00100.0040.0042.8630.003.85-66.67200.0062.96-45.4570.83-34.15-22.2247.6216.13116.67
60.0060.0064.2965.0061.5462.9655.5659.2665.9158.3358.5440.7440.7440.7440.7440.74
3.006.009.0013.0016.0017.005.0016.0029.0014.0024.0011.008.5612.6314.6731.78
-3.00––-3.00-2.00-1.00-8.004.0014.00–8.00-10.002.004.004.0010.00
-60.00––-15.00-7.69-3.70-88.8914.8131.82–19.51-37.049.5212.9011.1112.82
-3.00––-3.00-2.00-1.00-6.004.0024.00–6.00-7.00-6.00-1.00–11.00
––––-33.33-50.00500.00-166.67500.00––-216.67-14.29-83.33––
16.3311.2013.5513.2515.9716.0416.4516.6016.5816.2716.4416.3316.3316.3316.3316.33
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sensus Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sensus Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sensus Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sensus Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sensus Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sensus Healthcare stock margins

The Sensus Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sensus Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sensus Healthcare.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
62.82 %
15.24 %
15.23 %
Jan 1, 2022
66.53 %
33.30 %
54.44 %
Jan 1, 2023
57.61 %
-1.57 %
1.99 %
Jan 1, 2024
58.44 %
19.35 %
15.90 %
Jan 1, 2025
43.18 %
-37.50 %
-28.09 %
Jan 1, 2026 (e)
43.18 %
13.47 %
-31.00 %
Jan 1, 2027 (e)
43.18 %
13.47 %
-5.99 %
Jan 1, 2028 (e)
43.18 %
13.47 %
2.45 %

Sensus Healthcare Stock Revenue, EBIT, Earnings per Share

The Sensus Healthcare earnings per share therefore indicates how much revenue Sensus Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
1.63 USD
0.25 USD
0.25 USD
Jan 1, 2022
2.69 USD
0.89 USD
1.46 USD
Jan 1, 2023
1.50 USD
-0.02 USD
0.03 USD
Jan 1, 2024
2.54 USD
0.49 USD
0.40 USD
Jan 1, 2025
1.68 USD
-0.63 USD
-0.47 USD
Jan 1, 2026 (e)
1.35 USD
0.18 USD
-0.42 USD
Jan 1, 2027 (e)
1.92 USD
0.26 USD
-0.12 USD
Jan 1, 2028 (e)
2.24 USD
0.30 USD
0.06 USD

Sensus Healthcare business model & stock analysis

Sensus Healthcare Inc is a US-based medical technology company specializing in the development, manufacturing, and distribution of medical devices for non-invasive treatment of skin cancer and other skin conditions. The company was founded in 2010 by Kalman Fishman and is headquartered in Boca Raton, Florida.

Sensus Healthcare SWOT Analysis

Strengths

1. Advanced Technology: Sensus Healthcare Inc benefits from its state-of-the-art technology, allowing it to offer innovative and effective medical devices for skin cancer treatment.

2. Strong Market Position: With a well-established presence in the healthcare industry, Sensus Healthcare Inc has achieved a significant market share and brand recognition in the dermatology field.

3. Experienced Management Team: The company is led by a skilled and knowledgeable management team with extensive expertise in the medical device sector, contributing to effective decision-making and strategic planning.

Weaknesses

1. Limited Product Portfolio: Sensus Healthcare Inc primarily focuses on skin cancer treatment devices, which may limit its revenue potential compared to companies with diversified product offerings.

2. Dependence on Healthcare Regulations: Changes or tightening of healthcare regulations can impact the company's ability to operate or market its products effectively, potentially causing disruptions in its business operations.

3. Relatively Small Scale: Compared to larger competitors, Sensus Healthcare Inc's smaller size and resources may restrict its ability to invest extensively in research and development, limiting its ability to introduce new products or expand into new markets.

Opportunities

1. Growing Demand for Skin Cancer Treatment: The increasing prevalence of skin cancer and rising awareness among individuals about early diagnosis and treatment provide an opportunity for Sensus Healthcare Inc to capitalize on a growing market.

2. International Expansion: Exploring new markets beyond its current geographic reach could enable Sensus Healthcare Inc to diversify its customer base and increase revenue streams.

3. Collaborations and Partnerships: Forming strategic partnerships with dermatology clinics, hospitals, and research institutions can bring about synergies, enhance product development, and facilitate market penetration.

Threats

1. Intense Competition: Sensus Healthcare Inc faces competition from larger medical device companies as well as emerging startups, which could potentially erode its market share or pressure its pricing strategy.

2. Regulatory Challenges: Changes in government regulations, compliance requirements, and obtaining necessary approvals may pose challenges for Sensus Healthcare Inc, impacting its ability to bring new products to market in a timely manner.

3. Economic Volatility: Unpredictable economic conditions, such as a recession or financial crisis, can affect consumer spending and healthcare budgets, potentially reducing demand for Sensus Healthcare Inc's products.

Sensus Healthcare Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Sensus Healthcare Employees
Details
Date
Sensus Healthcare Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Sensus Healthcare Segments

Sensus Healthcare Revenue by Segment

  • 3 Years

  • 5 Years

  • Max

Product
Service revenue
Service
Product revenue
Details
Date
Product
Service revenue
Service
Product revenue
Jan 1, 2018
0.00 USD
24.65 M USD
0.00 USD
1.78 M USD
0.00 USD
Jan 1, 2019
0.00 USD
25.11 M USD
0.00 USD
2.15 M USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
4.13 M USD
0.00 USD
5.45 M USD
Jan 1, 2021
22.22 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
36.40 M USD
3.20 M USD
1.96 M USD
247,000.00 USD
Jan 1, 2025
0.00 USD
19.76 M USD
3.46 M USD
2.54 M USD
1.72 M USD

Sensus Healthcare Revenue by Region

  • Max

United States
CHINA
ISRAEL
Other Countries
GUATEMALA
IRELAND
TÜRKIYE
Details
Date
United States
CHINA
ISRAEL
Other Countries
GUATEMALA
IRELAND
TÜRKIYE
Jan 1, 2024
40.18 M USD
1.45 M USD
172,000.00 USD
10,000.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
25.36 M USD
2.03 M USD
0.00 USD
90,000.00 USD
0.00 USD
0.00 USD
0.00 USD

Sensus Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sensus Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Sensus Healthcare annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sensus Healthcare shares outstanding

The number of shares of Sensus Healthcare was 16.33 M in 2025. This indicates how many shares Sensus Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
16.60 M Stocks
Jan 1, 2022
16.58 M Stocks
Jan 1, 2023
16.27 M Stocks
Jan 1, 2024
16.44 M Stocks
Jan 1, 2025
16.33 M Stocks
Jan 1, 2026 (e)
16.33 M Stocks
Jan 1, 2027 (e)
16.33 M Stocks
Jan 1, 2028 (e)
16.33 M Stocks

Current Sensus Healthcare forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
25.00 %
Buy
88.89 % (8)
Hold
11.11 % (1)
Sell
0.00 % (0)
12M Price Target
6.12
Last Price
2.91
Currency
USD
12M Return Potential
110.31 %
LTM Return
0 %

Sensus Healthcare Analyst Rating Actions

DateFirmActionRating
2/17/2026
Maxim Group
Maxim Group
MaintainedBuy
8/12/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
8/8/2025
Lake Street
Lake Street
MaintainedBuy
5/19/2025
Maxim Group
Maxim Group
MaintainedBuy
4/4/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
3/11/2025
Lake Street
Lake Street
MaintainedBuy
2/10/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
11/18/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
11/15/2024
Maxim Group
Maxim Group
MaintainedBuy
8/12/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy

Sensus Healthcare Earnings Calls

2025

Sensus Healthcare Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/13/2026-0.13USD-4.69 MUSD-2026 Q2
4/30/2026-0.13USD-5.43 MUSD-2026 Q1
2/12/2026-0.07USD-8.51 MUSD-2025 Q4
11/14/2024-0.01USD-6.01 MUSD-2024 Q3
5/1/2024-0.03USD-5.67 MUSD-2024 Q1
2/7/20240.02USD-7.67 MUSD-2023 Q4
8/2/20230.26USD-13.79 MUSD-2023 Q2
5/3/20230.17USD-11.26 MUSD-2023 Q1
2/8/20230.21USD-12.43 MUSD-2022 Q4
11/3/20220.13USD-9.68 MUSD-2022 Q3

Sensus Healthcare shareholder structure

% Name
7.35163%
Sardano (Joseph C)
Sardano (Joseph C)
4.46451%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
4.27904%
Pacific Ridge Capital Partners, LLC
Pacific Ridge Capital Partners, LLC
2.71722%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
1.96661%
Florida State Board of Administration
Florida State Board of Administration
1.83059%
Divisadero Street Capital Management, LP
Divisadero Street Capital Management, LP
...

Sensus Healthcare Beneficial Ownership Filings (SEC 13D/G)

Free Float
82.3%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
8.70%
The Babcock & Wilcox Company (“B&W”)
The Babcock & Wilcox Company (“B&W”)
SEC ↗
7.60%
Edwin L. Solot, Jr.
Edwin L. Solot, Jr.
SEC ↗
7.10%
Joseph C. Sardano
Joseph C. Sardano
SEC ↗
6.74%
RTW INVESTMENTS, LLC
RTW INVESTMENTS, LLC
SEC ↗
6.74%
Roderick Wong
Roderick Wong
SEC ↗
6.59%
RTW MASTER FUND, LTD.
RTW MASTER FUND, LTD.
SEC ↗
5.56%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
2.44%
S
S
SEC ↗

Sensus Healthcare Executives and Management Board

9 members · avg. age 50 · 22 % women

MS

Mr. Michael Sardano (37)

President, General Counsel, Corporate Secretary, Chief Commercial Officer, Director · since 2017

1.28 M USD

Management

JS

Mr. Joseph Sardano (72)

Chairman of the Board, Chief Executive Officer, Co-Founder · since 2010

1.27 M USD
JR

Mr. Javier Rampolla (53)

Chief Financial Officer

656,045.00 USD
MM

Ms. Magdalena Martinez (35)

Chief Operating Officer

–
ES

Mr. Emiliano Sosa (48)

Chief Technology Officer

–

Board of Directors

MC

Ms. Megan Cornish (40)

Non-Employee Independent Director

235,600.00 USD
AP

Mr. Anthony Petrelli (72)

Non-Employee Independent Director

235,600.00 USD
LB

Mr. Larry Biscotti (52)

Director

–
ES

Mr. Eric Sachetta (37)

Independent Director

–

Sensus Healthcare Supply Chain

Frequently asked questions about Sensus Healthcare

Sensus Healthcare Inc is a medical device company specializing in non-invasive treatment solutions for skin cancer and other skin conditions. The business model of Sensus Healthcare revolves around developing, manufacturing, and marketing advanced technologies, such as the SRT-100™, to dermatologists, oncologists, and other healthcare professionals. The company aims to provide cost-effective and efficient alternatives to traditional treatment methods, ensuring improved patient outcomes with minimal side effects. With a focus on innovation and patient-centric solutions, Sensus Healthcare strives to address the growing demand for non-invasive and non-surgical options in the field of dermatology.

Sensus Healthcare Inc is primarily active in the healthcare industry.

The main competitors of Sensus Healthcare Inc in the market include Varian Medical Systems Inc, Cutera Inc, and Elekta AB.

Sensus Healthcare Inc. is a renowned medical device company specializing in non-invasive treatments for various skin cancers and other dermatological conditions. Founded in 2010, Sensus Healthcare has grown into a global leader in superficial radiation therapy (SRT) technology. Their flagship product, the SRT-100™, provides effective, painless, and non-surgical treatment options to patients around the world. With a strong focus on innovation and patient-centric approach, Sensus Healthcare continues to revolutionize the field of dermatology. As a result, it is recognized for its cutting-edge technology, exceptional clinical outcomes, and dedication to improving the quality of life for patients with skin disorders.

Sensus Healthcare Inc has achieved several significant milestones. Firstly, the company received FDA clearance for its Scalp and Superficial Radiation Therapy System in 2005, allowing it to provide non-invasive treatments for various skin conditions. Additionally, Sensus Healthcare was listed on the NASDAQ stock exchange in 2016, further solidifying its presence in the market. In recent years, the company has expanded its global reach, establishing partnerships and increasing its customer base worldwide. Sensus Healthcare Inc also continues to innovate, developing advanced technologies and treatment solutions to improve patient outcomes. These milestones showcase the company's dedication to advancing dermatological care and its commitment to growth and innovation.

Sensus Healthcare Inc is primarily present in the United States, with their headquarters located in Boca Raton, Florida. As a global medical device company, they have a widespread presence across various states and cities within the US. Additionally, Sensus Healthcare Inc has expanded its reach to numerous other countries and regions worldwide, including Europe, Asia, and Latin America. With a commitment to providing innovative solutions for non-invasive skin cancer treatment, Sensus Healthcare Inc continues to extend its presence and impact in the international market.

Sensus Healthcare Inc represents a set of core values and a corporate philosophy that drives its operations. The company aims to deliver innovative and effective solutions for non-invasive skin cancer treatment. With a focus on patient care and quality, Sensus Healthcare strives to provide advanced technology and therapies to improve treatment outcomes. By offering personalized solutions and maintaining strong ethical standards, Sensus Healthcare ensures that patients receive the best possible care. The company's commitment to research, development, and collaboration with healthcare professionals reflects its dedication to advancing the field of dermatology and oncology. Sensus Healthcare Inc sets high standards in delivering exceptional services to patients worldwide.

Analysts currently set an average price target of 6.80 USD for the Sensus Healthcare stock (median: 6.12 USD), implying +133.7 % versus the latest price. The consensus is based on 9 analyst ratings.

Sensus Healthcare Analyst Price Targets 2026

9 analysts currently rate the Sensus Healthcare stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sensus Healthcare to generate revenue of 21.99 M USD and earnings per share of -0.42 USD.

Sensus Healthcare Analyst Price Targets 2026

Converted at the current exchange rate, the Sensus Healthcare share trades at 2.52 EUR (2.91 USD).

The Sensus Healthcare share (SRTS) is listed on 4 stock exchanges, including: NASDAQ (SRTS), Frankfurt (5TX.F), München (5TX.MU), Düsseldorf (5TX.DU).

Sensus Healthcare Inc. is an innovative company specializing in the development and marketing of medical devices and solutions for dermatology and oncology. The company offers a wide range of products and services aimed at the treatment of skin cancer, psoriasis, and other dermatological conditions. The business model of Sensus Healthcare focuses on the following areas: 1. Distribution of medical devices and solutions: Sensus Healthcare distributes a range of medical devices and solutions used in modern medicine for the treatment of skin cancer, psoriasis, and other dermatological conditions. These include the Superficial Radiation Therapy (SRT) system, electronic brachytherapy system, and phototherapy solutions. 2. Consumables and accessories: The company also offers various consumables and accessories for the medical devices it provides. These consumables include X-ray films, protective films, and electrodes. 3. Services and support: In addition to selling medical devices and accessories, Sensus Healthcare also offers various services and support to its customers. These include training and technical support, installation services, as well as maintenance and repair services. Sensus Healthcare has also focused on continuously improving the quality and effectiveness of its products. The company has established an extensive research and development program that allows it to constantly improve its products and introduce new innovative solutions to the market. Another important aspect of Sensus Healthcare's business model is its direct collaboration with doctors and medical facilities worldwide. The company has built a global network of distribution partners and collaborators to provide better coverage and support to its customers. In terms of its products, Sensus Healthcare offers a variety of solutions including: 1. The Superficial Radiation Therapy (SRT) system is a non-invasive, painless treatment method specifically designed for skin cancer, basal cell carcinoma, and other dermatological conditions. The SRT system delivers targeted radiation therapy that only treats the affected areas of the skin without damaging the surrounding tissue or organs. 2. The electronic brachytherapy system is another therapy option offered by Sensus Healthcare. This system can deliver targeted radioactive radiation directly into the tumor to destroy cancer cells. The electronic brachytherapy system is particularly effective in the treatment of skin cancer, melanoma, and other malignant skin conditions. 3. Phototherapy solutions are also an important part of Sensus Healthcare's offerings. Phototherapy is a non-invasive treatment that uses targeted ultraviolet light to treat psoriasis, eczema, and other skin conditions. Overall, Sensus Healthcare's business model is characterized by a targeted focus on providing innovative medical devices and solutions. Through its wide range of products, extensive support network, and emphasis on collaboration with medical facilities worldwide, the company has achieved a strong position in the industry.

The expected revenue of Sensus Healthcare is 21.99 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Sensus Healthcare is -6.82 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sensus Healthcare is currently -6.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sensus Healthcare stock.

The price-to-sales ratio (P/S) of Sensus Healthcare is currently 2.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sensus Healthcare stock.

The Eulerpool Quality Score for Sensus Healthcare is 1/10.

The ISIN of Sensus Healthcare is US81728J1097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Sensus Healthcare is A2JPJ1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Sensus Healthcare is SRTS. The ticker symbol is used to trade Sensus Healthcare shares on the stock exchange.

Sensus Healthcare paid dividends every year for the past 0 years.

Sensus Healthcare is assigned to the 'Health' sector.

The dividends of Sensus Healthcare are distributed in USD.

All fundamentals and in-depth analysis of Sensus Healthcare

Our stock analysis for Sensus Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensus Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sensus Healthcare Stock
Sensus Healthcare Revenue→
Sensus Healthcare Stock
Sensus Healthcare Net Income→
Sensus Healthcare Stock
Sensus Healthcare P/E→
Sensus Healthcare Stock
Sensus Healthcare P/S→
Sensus Healthcare Stock
Sensus Healthcare EBIT→
Sensus Healthcare Stock
Sensus Healthcare Dividend→
Sensus Healthcare Stock
Sensus Healthcare Directors Dealings→
Sensus Healthcare Stock
Sensus Healthcare Stocks→
Sensus Healthcare Stock
Sensus Healthcare Market capitalization→
Sensus Healthcare Stock
Sensus Healthcare Debt→
Sensus Healthcare Stock
Sensus Healthcare Liabilities→
Sensus Healthcare Stock
Sensus Healthcare Equity→
Sensus Healthcare Stock
Sensus Healthcare AAQS→
Sensus Healthcare Stock
Sensus Healthcare Employees→
Sensus Healthcare Stock
Sensus Healthcare ROE→
Sensus Healthcare Stock
Sensus Healthcare ROA→
Sensus Healthcare Stock
Sensus Healthcare ROCE→
Sensus Healthcare Stock
Sensus Healthcare News→
Sensus Healthcare Stock
Sensus Healthcare Analyst Price Targets→

Health Stocks

Senti BiosciencesSensorionSenzaGenSenseonics HoldingsSenzime AB (publ)Sensei BiotherapeuticsSeoul Pharma CoSenhwa BiosciencesSeouleaguer CoSenestechSeoulin Bioscience CoSelvitaAll Stocks A–Z →